102555 | Abl Protein Tyrosine Kinase, Recombinant, E. coli

102555
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1102555-2000U
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente

          Ampolla de plást. 2000 u
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewRecombinant, truncated form of the v-Abl protein tyrosine kinase that contains the minimum region required for both kinase activity and fibroblast transformation expressed in E. coli. The catalytic domain of v-Abl is identical to that of c-Abl. Induces resistance to anti-cancer drugs by suppressing apoptosis, probably by upregulating Bcl-xL protein.
          Catalogue Number102555
          Brand Family Calbiochem®
          Synonymsv-Abl
          References
          ReferencesChen, Q., et al. 1997. Oncogene 15, 2249.
          Chapman, R.S., et al. 1995. Mol. Pharmacol. 48, 334.
          Evans, C.A., et al. 1995. J. Cell Sci. 108, 2591.
          Foulkes, J.G., et al. 1985. J. Biol. Chem. 260, 8070.
          Product Information
          Activity≥100,000 units/ml
          Unit of DefinitionOne unit is defined as the amount of enzyme that will catalyze the transfer of 1.0 pmol phosphate to EAIYAAPFAKKK per min at 30°C, pH 7.5.
          FormLiquid
          FormulationIn 100 mM NaCl, 50 mM HEPES, 1 mM DTT, 100 µM EDTA, 50% glycerol, 0.01% BRIJ® 35 Detergent, pH 7.5.
          Applications
          Biological Information
          Concentration Label Please refer to vial label for lot-specific concentration
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          Certificados de análisis

          CargoNúmero de lote
          102555

          Referencias bibliográficas

          Visión general referencias
          Chen, Q., et al. 1997. Oncogene 15, 2249.
          Chapman, R.S., et al. 1995. Mol. Pharmacol. 48, 334.
          Evans, C.A., et al. 1995. J. Cell Sci. 108, 2591.
          Foulkes, J.G., et al. 1985. J. Biol. Chem. 260, 8070.
          Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision26-June-2009 JSW
          Synonymsv-Abl
          DescriptionRecombinant, truncated form of the v-Abl protein tyrosine kinase that contains the minimum region required for both kinase activity and fibroblast transformation expressed in E. coli. The catalytic domain of v-abl is identical to that of c-abl. Induces resistance to anti-cancer drugs by suppressing apoptosis. Also involved in the upregulation of Bcl-xL protein.
          FormLiquid
          FormulationIn 100 mM NaCl, 50 mM HEPES, 1 mM DTT, 100 µM EDTA, 50% glycerol, 0.01% BRIJ® 35 Detergent, pH 7.5.
          Concentration Label Please refer to vial label for lot-specific concentration
          Recommended reaction conditions1x kinase buffer: 50 mM Tris-HCl, 10 mM MgCl2, 100 µM EDTA, 1 mM DTT, 100 µM ATP (γ-ATP to 100 µCi/µmol), 0.015% BRIJ® 35 detergent, and 100 µg/ml BSA. Incubate at 30°C. Note: optimal reaction conditions need to be established empirically for each substrate.
          Activity≥100,000 units/ml
          Unit definitionOne unit is defined as the amount of enzyme that will catalyze the transfer of 1.0 pmol phosphate to EAIYAAPFAKKK per min at 30°C, pH 7.5.
          Storage ≤ -70°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Toxicity Standard Handling
          ReferencesChen, Q., et al. 1997. Oncogene 15, 2249.
          Chapman, R.S., et al. 1995. Mol. Pharmacol. 48, 334.
          Evans, C.A., et al. 1995. J. Cell Sci. 108, 2591.
          Foulkes, J.G., et al. 1985. J. Biol. Chem. 260, 8070.